| [1] |
Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Inspire-CODA Research Group.
Expert consensus on the treatment of tuberculosis with contezolid
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 123-129.
|
| [2] |
Li Xuelian, Zhang Hongyan, Wang Jun, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan.
Safety of extended delamanid use in drug-resistant tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 164-168.
|
| [3] |
Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan.
Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180.
|
| [4] |
Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei.
Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60.
|
| [5] |
Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei.
Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062.
|
| [6] |
Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei.
Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097.
|
| [7] |
Shi Lulu, Jing Hui, Liang Min, Li Xuezheng.
Analysis of clinical results of blood concentration detection of antituberculosis drugs by liquid chromatography-tandem mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 886-891.
|
| [8] |
Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong.
Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896.
|
| [9] |
Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping.
Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 648-653.
|
| [10] |
Duan Shujuan, Wang Wei, Pang Yu, Li Ling.
Research progress on the regulation of host anti-tuberculosis effect by tyrosine kinase inhibitors
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 584-589.
|
| [11] |
Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin.
Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423.
|
| [12] |
Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan.
Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020
[J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339.
|
| [13] |
Jiayinati Jingesi, Wang Xinqi, Liu Nianqiang, Wang Senlu, Yipaer Aihaiti, Feng Jianyu, Huang Tao, Kedieryekezi Wufuer.
Analysis of treatment completeness and its influencing factors of preventive treatment among 387 latent tuberculosis infection cases
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1496-1503.
|
| [14] |
Shi Chunjing, Liu Xing, Li Longfen, Li Wenming, Zhang Huajie, Wang Ge, Zeng Haiyan, Liu Li, Shen Lingjun.
Research progress on the effects of bedaquiline,delamanid and pretomanid on liver function in the treatment of multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1560-1565.
|
| [15] |
Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan.
An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
